Huvos Ag
About
In The Last Decade
Huvos Ag
34 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 71
- Pulmonary and Respiratory Medicine 764
- Rheumatology 441
- Oncology 403
- Surgery 291
- Pathology and Forensic Medicine 217
Countries citing papers authored by Huvos Ag
This map shows the geographic impact of Huvos Ag's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Huvos Ag with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Huvos Ag more than expected).
Fields of papers citing papers by Huvos Ag
This network shows the impact of papers produced by Huvos Ag. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Huvos Ag. The network helps show where Huvos Ag may publish in the future.
Co-authorship network of co-authors of Huvos Ag
This figure shows the co-authorship network connecting the top 25 collaborators of Huvos Ag. A scholar is included among the top collaborators of Huvos Ag based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Huvos Ag. Huvos Ag is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 12 | |
| 2 | Osteosarcoma in adolescents and young adults: new developments and controversies. Commentary on pathology. | 7 |
| 3 | Cryosurgery in osteogenic sarcoma: report of three cases. | 15 |
| 4 | Prognostic factors in the response of primary osteogenic sarcoma to preoperative chemotherapy (high-dose methotrexate with citrovorum factor). | 14 |
| 5 | Combination chemotherapy (T-6) in the multidisciplinary treatment of Ewing's sarcoma. | 20 |
| 6 | Osteogenic sarcoma: eight-percent, three-year, disease-free survival with combination chemotherapy (T-7). | 25 |
| 7 | Primary leiomyosarcoma of bone. | 33 |
| 8 | Clinicopathologic spectrum of osteogenic sarcoma. Recent observations. | 14 |
| 9 | Parosteal (juxtacortical) osteogenic sarcoma. A roentgenological study of 30 patients. | 13 |
| 10 | Total femur replacement. | 9 |
| 11 | 70 | |
| 12 | Axillary micrometastasis and macrometastasis in carcinoma of the breast. | 43 |
| 13 | Primary malignant fibrous histiocytoma of bone; clinicopathologic study of 18 patients. | 59 |
| 14 | 70 | |
| 15 | Metaplastic breast carcinoma. Rare form of mammary cancer. | 119 |
| 16 | Hamartomas of the lung. | 14 |
| 17 | Granular-cell myoblastoma of breast. | 3 |
| 18 | Hamartomas of the liver. | 8 |
| 19 | Carcinoma of female urethra. Occurrence with hyperparathyroidism. | 9 |
| 20 | Smooth muscle involvement in primary muscle disease. II. Progressive muscular dystrophy. | 19 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.